Ipilimumab (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ipilimumab" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

6nih.gov

4^th place

8^th place

4doi.org

2^nd place

5^th place

3europa.eu

68^th place

28^th place

3books.google.com

3^rd place

11^th place

2web.archive.org

1^st place

2^nd place

2archive.org

6^th place

9^th place

1biocentury.com

low place

1ama-assn.org

3,257^th place

1,590^th place

1termania.net

low place

34^th place

1medicines.org.uk

3,823^rd place

3,244^th place

1fda.gov

447^th place

409^th place

1novapublishers.com

low place

1nytimes.com

7^th place

37^th place

1onkologija.org

low place

2,870^th place

ama-assn.org

USAN. »STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - ipilimumab« (tiskovna objava). American Medical Association (AMA). Arhivirano iz prvotnega spletišča dne 23. februarja 2016. Pridobljeno 12. januarja 2013.

archive.org

Antoni Ribas (28. junij 2012). »Tumor immunotherapy directed at PD-1«. New England Journal of Medicine. 366 (26): 2517–2519. doi:10.1056/nejme1205943. PMID 22658126.
Ralph Blum; Mark Scholz (24. avgust 2010). Invasion of the Prostate Snatchers: No More Unnecessary Biopsies, Radical Treatment Or Loss of Sexual Potency. Other Press, LLC. str. 227–. ISBN 978-1-59051-342-2. Pridobljeno 30. marca 2011.

biocentury.com

»Yervoy, ipilimumab (BMS-734016) - Product Profile - BioCentury«. BioCentury Online Intelligence. BioCentury Publications. Pridobljeno 11. avgusta 2016.

books.google.com

Gail M. Wilkes; Margaret Barton-Burke (11. december 2009). 2010 oncology nursing drug handbook. Jones & Bartlett Learning. str. 1–. ISBN 978-0-7637-8124-8. Pridobljeno 30. marca 2011.
L. Harivardhan Reddy; Patrick Couvreur (1. junij 2009). Macromolecular Anticancer Therapeutics. Springer. str. 522–. ISBN 978-1-4419-0506-2. Pridobljeno 30. marca 2011.
Zhiqiang An (8. september 2009). Therapeutic Monoclonal Antibodies: From Bench to Clinic. John Wiley and Sons. str. 134–. ISBN 978-0-470-11791-0. Pridobljeno 30. marca 2011.

doi.org

Syn NL, Teng MW, Mok TS, Soo RA (december 2017). »De-novo and acquired resistance to immune checkpoint targeting«. The Lancet Oncology. 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Antoni Ribas (28. junij 2012). »Tumor immunotherapy directed at PD-1«. New England Journal of Medicine. 366 (26): 2517–2519. doi:10.1056/nejme1205943. PMID 22658126.
Tarhini AA, Iqbal F (2010). »CTLA-4 blockade: therapeutic potential in cancer treatments«. OncoTargets Ther. 3: 15–25. doi:10.2147/ott.s4833. PMC 2895779. PMID 20616954.
Robert C, Ghiringhelli F (Avgust 2009). »What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma?«. Oncologist. 14 (8): 848–61. doi:10.1634/theoncologist.2009-0028. PMID 19648604.

europa.eu

ema.europa.eu

»Yervoy EPAR«. Evropska agencija za zdravila (EMA). Pridobljeno 20. novembra 2023.
https://www.ema.europa.eu/en/documents/product-information/yervoy-epar-product-information_sl.pdf Evropska agencija za zdravila. Povzetek glavnih značilnosti zdravila Yervoy, vpogled: 3. 5. 2021.
https://www.ema.europa.eu/en/documents/overview/yervoy-epar-medicine-overview_sl.pdf Evropska agencija za zdravila. EPAR - Yervoy, vpogled: 3. 5. 2021.

fda.gov

accessdata.fda.gov

»Drug Approval Package: Yervoy (ipilimumab) Injection NDA #125377«. U.S. Food and Drug Administration (FDA). 16. maj 2011. Pridobljeno 2. oktobra 2020.

medicines.org.uk

»Yervoy 5 mg/ml concentrate for solution for infusion - Summary of Product Characteristics (SmPC)«. (emc). 3. avgust 2020. Pridobljeno 2. oktobra 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Syn NL, Teng MW, Mok TS, Soo RA (december 2017). »De-novo and acquired resistance to immune checkpoint targeting«. The Lancet Oncology. 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Antoni Ribas (28. junij 2012). »Tumor immunotherapy directed at PD-1«. New England Journal of Medicine. 366 (26): 2517–2519. doi:10.1056/nejme1205943. PMID 22658126.
Tarhini AA, Iqbal F (2010). »CTLA-4 blockade: therapeutic potential in cancer treatments«. OncoTargets Ther. 3: 15–25. doi:10.2147/ott.s4833. PMC 2895779. PMID 20616954.
Robert C, Ghiringhelli F (Avgust 2009). »What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma?«. Oncologist. 14 (8): 848–61. doi:10.1634/theoncologist.2009-0028. PMID 19648604.

dailymed.nlm.nih.gov

»Yervoy- ipilimumab injection«. DailyMed. 13. avgust 2020. Pridobljeno 2. oktobra 2020.

ncbi.nlm.nih.gov

Tarhini AA, Iqbal F (2010). »CTLA-4 blockade: therapeutic potential in cancer treatments«. OncoTargets Ther. 3: 15–25. doi:10.2147/ott.s4833. PMC 2895779. PMID 20616954.

novapublishers.com

Lacroix, Marc (2014). Targeted Therapies in Cancer. Hauppauge, NY: Nova Sciences Publishers. ISBN 978-1-63321-687-7. Arhivirano iz prvotnega spletišča dne 26. junija 2015. Pridobljeno 13. julija 2014.

nytimes.com

Pollack, Andrew (29. maj 2015). »New Class of Drugs Shows More Promise in Treating Cancer«. New York Times. Pridobljeno 30. maja 2015.

onkologija.org

http://www.onkologija.org/wp-content/uploads/Zlozenka-knjizica_Melanom_2020_zaSplet-1.pdf Kožni melanom – Kaj mora vsakdo vedeti o tej bolezni. Društvo onkoloških bolnikov Slovenije, Ljubljana 2020. Dostop: 3. 5. 2021.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/8398307/ipilimumab?query=ipilimumab&SearchIn=All Slovenski medicinski e-slovar, vpogled: 3. 5. 2021.

web.archive.org

USAN. »STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - ipilimumab« (tiskovna objava). American Medical Association (AMA). Arhivirano iz prvotnega spletišča dne 23. februarja 2016. Pridobljeno 12. januarja 2013.
Lacroix, Marc (2014). Targeted Therapies in Cancer. Hauppauge, NY: Nova Sciences Publishers. ISBN 978-1-63321-687-7. Arhivirano iz prvotnega spletišča dne 26. junija 2015. Pridobljeno 13. julija 2014.